Evidence map›Paper›PMID 30501024›Full record

ArticleInternational journal of molecular sciences2018

The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.

Philipp Schwenkenbecher, Franz Felix Konen, Ulrich Wurster, Konstantin Fritz Jendretzky, Stefan Gingele, Kurt-Wolfram Sühs, Refik Pul, Torsten Witte, Martin Stangel, Thomas Skripuletz

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07183020 (Prospective, Multicentric, Real-world Investigation of Kappa Free Light Chains), which is not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07183020 enrolling by invitationnot on this mapstarted 2022, after this paper: background citation

Prospective, Multicentric, Real-world Investigation of Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)

TypeobservationalSponsorSkripuletz, Thomas Prof. Dr.Ran2022 to 2026Enrolled1,142ConditionsMultiple Sclerosis, Clinically Isolated Syndrome (CIS)ArmsOligoclonal bands and kappa free light chains (KFLC)
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Frontiers in neurology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Philipp SchwenkenbecherClinical Neuroimmunology and Neurochemistry, Department of Neurology, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. schwenkenbecher.philipp@mh-hannover.de.ORCID 0000-0002-1260-1650
Franz Felix KonenClinical Neuroimmunology and Neurochemistry, Department of Neurology, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Konen.Felix@mh-hannover.de.
Ulrich WursterClinical Neuroimmunology and Neurochemistry, Department of Neurology, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. wurster.ulrich@mh-hannover.de.
Konstantin Fritz JendretzkyClinical Neuroimmunology and Neurochemistry, Department of Neurology, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Jendretzky.Konstantin@mh-hannover.de.
Stefan GingeleClinical Neuroimmunology and Neurochemistry, Department of Neurology, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Gingele.Stefan@mh-hannover.de.
Kurt-Wolfram SühsClinical Neuroimmunology and Neurochemistry, Department of Neurology, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Suehs.Kurt-Wolfram@mh-hannover.de.ORCID 0000-0002-8077-481X
Refik PulDepartment of Neurology, University Clinic Essen, Hufelandstraße 55, 45147 Essen, Germany. Refik.Pul@uk-essen.de.
Torsten WitteDepartment of Clinical Immunology and Rheumatology, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Witte.Torsten@mh-hannover.de.
Martin StangelClinical Neuroimmunology and Neurochemistry, Department of Neurology, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Stangel.Martin@mh-hannover.de.
Thomas SkripuletzClinical Neuroimmunology and Neurochemistry, Department of Neurology, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Skripuletz.Thomas@MH-Hannover.de.
Medizinische Hochschule Hannover · DEEssen University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The latest revision of the McDonald criteria of 2017 considers the evidence of an intrathecal immunoglobulin (IgG) synthesis as a diagnostic criterion for dissemination in time in multiple sclerosis. While the detection of oligoclonal bands is considered as the gold standard, determination of kappa free light chains might be a promising tool as a less technically demanding and cost saving method. However, data on the direct comparison between kappa free light chains and oligoclonal bands are limited and no study to date has used the highly sensitive method of polyacrylamide gels with consecutive silver staining for the demonstration of oligoclonal bands. Furthermore, the impact of the revised McDonald criteria of 2017 on the role of kappa free light chains as a biomarker has not been investigated. Nephelometry was used to determine kappa free light chains in cerebrospinal fluid (CSF) and serum from 149 patients with their first demyelinating event between 2010 and 2015. Clinical data, kappa free light chains, and oligoclonal band status were compared at the time of initial diagnosis and after follow-up to identify converters from clinically isolated syndrome to multiple sclerosis. An elevated kappa free light chain index (>5.9) was found in 79/83 patients (95%) with multiple sclerosis diagnosed at baseline, slightly less frequent than oligoclonal bands (98.8%). 18/25 (72%) patients who converted from clinically isolated syndrome to multiple sclerosis showed an elevated kappa free light chain index compared to 20/25 (80%) patients with positive oligoclonal bands. In patients with stable clinically isolated syndrome 7/41 (17%) displayed an elevated kappa free light chain index against 11/41 (27%) oligoclonal band positive patients. Only two patients with stable clinically isolated syndrome showed an elevated kappa free light chain index but were oligoclonal bands negative. In conclusion, determination of the kappa free light chain index is a promising diagnostic approach to assess intrathecal immunoglobulin synthesis in multiple sclerosis. Nevertheless, oligoclonal bands are highly prevalent in multiple sclerosis and can detect an intrathecal synthesis of IgG even when the kappa free light chain index is below the threshold. We consider sequential use of both methods as reasonable.

Indexed as

Acrylic ResinsAdolescentAdultAgedFemaleHumansImmunoglobulin kappa-ChainsImmunoglobulin Light ChainsMaleMiddle AgedMultiple SclerosisNephelometry and TurbidimetryOligoclonal BandsPolyacrylamidesRetrospective StudiesYoung AdultAcrylic ResinsImmunoglobulin kappa-ChainsImmunoglobulin Light ChainsOligoclonal BandsPolyacrylamidesclinically isolated syndromekappa free light chainsMcDonald criteriamultiple sclerosisoligoclonal bandspolyacrylamide gel

Identifiers

PMID30501024
PMCPMC6320811
OpenAlexW2902850345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.